# Comparative Review: Exercise Therapy and CBD for Muscular Dystrophy > **Author:** Benjamin Caplan, MD (ABFM Board Certified, MA Lic. #240562, NPI: 1962722637) > **Publisher:** CED Clinic (https://cedclinic.com) > **Canonical URL:** https://cedclinic.com/muscular-dystrophy-exercise-therapy-muscle-preservation/ > **Published:** 2026-04-20T17:09:42-04:00 | **Last Modified / Clinically Audited:** 2026-09-28T17:04:19-04:00 > **Clinical Summary:** Explore muscular dystrophy exercise therapy as a key approach for muscle preservation, comparing benefits with cannabidiol supplementation. --- CED Clinical Relevance  #99High Clinical Relevance  Strong evidence or policy relevance with direct clinical implications. 🔬 Evidence Watch  |  CED Clinic Muscular DystrophyCbdExercise Therapy[Systematic Review](https://cedclinic.com/cannabinoid-safety-efficacy-mental-health-study/)Neuromuscular Journal Journal of biotechnology and biomedicine Study Type Randomized Trial Population Human participants Why This Matters Muscular dystrophy patients face progressive muscle degeneration with limited pharmaceutical options, making evidence-based non-pharmacologic interventions critical for clinical decision-making. This [systematic review](https://cedclinic.com/cannabinoid-safety-efficacy-mental-health-study/) directly compares established exercise therapy with emerging cannabidiol supplementation, providing clinicians with comparative efficacy data for muscle preservation strategies. Clinical Summary This systematic review compared exercise therapy versus cannabidiol supplementation for muscle preservation in muscular dystrophy patients. Exercise interventions (aerobic, resistance, functional training) showed consistent modest benefits in functional performance, endurance, and [quality of life](https://cedclinic.com/cannabis-policy-enforcement-february-26-2026/) with acceptable safety profiles when individualized. The cannabidiol evidence appears incomplete in the available abstract, suggesting limited clinical data compared to the more robust exercise literature. The review addresses a critical clinical gap given the absence of curative pharmacologic therapies for this progressive neuromuscular condition. Dr. Caplan’s Take “While I appreciate systematic attempts to evaluate CBD for neuromuscular conditions, the established exercise therapy literature far outweighs any cannabidiol evidence for muscular dystrophy. Without seeing completed CBD data from this review, I remain focused on evidence-based exercise prescriptions for these patients.” Clinical Perspective 🧠 Clinicians should continue prioritizing individualized exercise therapy programs as first-line non-pharmacologic intervention for muscular dystrophy patients, given the consistent evidence base. Any consideration of cannabidiol supplementation should await more robust clinical evidence and occur only as adjunctive therapy with appropriate monitoring and realistic expectations about limited supporting data. 💬 Join the Conversation Have a question about how this applies to your situation? [Ask Dr. Caplan →](https://benjamincaplan.com/ask-dr-caplan) Want to discuss this topic with other patients and caregivers? [Join the forum discussion →](https://cedclinic.com/interact/discussion-forums/forum/cannabis-industry/) Have thoughts on this? Share it: [𝕏 Share on X](https://twitter.com/intent/tweet?text=Just%20read%20this%20on%20CEDclinic.com%3A%20Muscular%20Dystrophy%20Muscle%20Preservation%3A%20A%20Comparative%20Systematic%20Review%20of%20Exerc...%20%40drcaplan&url=https%3A//pubmed.ncbi.nlm.nih.gov/42006603/)[in Share on LinkedIn](https://www.linkedin.com/sharing/share-offsite/?url=https%3A//pubmed.ncbi.nlm.nih.gov/42006603/)[🦥 Share on BlueSky](https://bsky.app/intent/compose?text=Just%20read%20this%3A%20Muscular%20Dystrophy%20Muscle%20Preservation%3A%20A%20Comparative%20Systematic%20Review%20of%20Exerc...%20--%20via%20%40drcaplan.bsky.social%20https%3A//pubmed.ncbi.nlm.nih.gov/42006603/)[📷 Follow on Instagram](https://www.instagram.com/drbenjamincaplan/)[📝 Read more on Substack](https://substack.com/@doctorapproved)[🔔 Subscribe via RSS](https://cedclinic.com/category/cannabis-news/feed/) 📰 Source: [https://pubmed.ncbi.nlm.nih.gov/42006603/](https://pubmed.ncbi.nlm.nih.gov/42006603/) Table of Contents - [FAQ](#FAQ)[Should exercise therapy be recommended for patients with muscular dystrophy?](#Should_exercise_therapy_be_recommended_for_patients_with_muscular_dystrophy) - [Is CBD supplementation currently recommended for muscular dystrophy patients?](#Is_CBD_supplementation_currently_recommended_for_muscular_dystrophy_patients) - [What types of exercise are most beneficial for muscular dystrophy patients?](#What_types_of_exercise_are_most_beneficial_for_muscular_dystrophy_patients) - [Are there any safety concerns with exercise therapy in muscular dystrophy?](#Are_there_any_safety_concerns_with_exercise_therapy_in_muscular_dystrophy) - [What are the main outcomes improved by exercise in muscular dystrophy patients?](#What_are_the_main_outcomes_improved_by_exercise_in_muscular_dystrophy_patients) - [Related](#Related) ## FAQ #### Should exercise therapy be recommended for patients with muscular dystrophy? Yes, exercise interventions including aerobic, resistance, and functional training demonstrate modest but consistent benefits in functional performance, endurance, and [quality of life](https://cedclinic.com/cannabis-policy-enforcement-february-26-2026/). When appropriately individualized, these interventions have acceptable safety profiles and represent an established cornerstone of conservative management. #### Is CBD supplementation currently recommended for muscular dystrophy patients? CBD supplementation is not currently recommended for routine clinical use in muscular dystrophy, as evidence is primarily limited to preclinical studies. More robust [clinical trials](https://cedclinic.com/endocannabinoid-system-emotional-memory-ptsd-treatment/) are needed to establish safety and efficacy in human patients before clinical implementation. #### What types of exercise are most beneficial for muscular dystrophy patients? The systematic review found that aerobic exercise, resistance training, and functional training all provide benefits when properly individualized. The key is appropriate customization based on the patient’s specific type of muscular dystrophy, disease stage, and functional capacity. #### Are there any safety concerns with exercise therapy in muscular dystrophy? Exercise therapy demonstrates acceptable safety profiles when appropriately individualized for each patient. Proper assessment and customization based on disease severity and functional status are essential to maximize benefits while minimizing potential risks. #### What are the main outcomes improved by exercise in muscular dystrophy patients? Exercise interventions consistently improve functional performance, endurance capacity, and quality of life measures. While the benefits are described as modest, they are consistent across different types of exercise interventions when properly implemented. [https://cedclinic.com/contact/](https://cedclinic.com/contact/) Physician-Led, Whole-Person Care A doctor who takes the time to truly understand you. Personal care that starts with listening and is guided by experience and ingenuity. Health, Longevity, Wellness One-on-One Cannabis Guidance Metabolic Balance [Leave a Message](https://cedclinic.com/contact/) [Metabolic Care](https://cedclinic.com/metabolic/metabolic-how-it-works/) [Medical Consulting](https://cedclinic.com/book/) [Cannabis Care](https://cedclinic.com/book/) [https://cedclinic.com/contact/](https://cedclinic.com/contact/) RELATED READING AT CED CLINIC Continue exploring the evidence [Muscular Dystrophy Muscle Preservation: A Comparative Systematic Review of Exercise and Cannabidiol (CBD) Interventions.](https://cedclinic.com/exercise-cbd-muscular-dystrophy-systematic-review-muscle-preservation/) An in-depth systematic review comparing exercise therapy and CBD supplementation for muscle preservation in muscular dystrophy patients. [Read the full review](https://cedclinic.com/exercise-cbd-muscular-dystrophy-systematic-review-muscle-preservation/) [Endocannabinoid System Research: Cannabis Mental Health Care](https://cedclinic.com/clinical-trial-cannabis-mental-health-research/) Explore research on the [endocannabinoid system](https://cedclinic.com/endocannabinoid-system-fear-extinction/) and its implications for mental health care and therapeutic interventions. [Explore research insights](https://cedclinic.com/clinical-trial-cannabis-mental-health-research/) [Cannabis Use Patterns and Perception of Acute Pain During Brief Abstinence: Sex-Dependent Associations](https://cedclinic.com/acute-pain-cannabinoid-withdrawal-sex-dependent-cannabis-study/) Study examining how [cannabis use](https://cedclinic.com/cannabis-cardiovascular-health-insights-2024/) affects acute pain perception and the role of sex differences in these associations. [Learn about cannabis and pain](https://cedclinic.com/acute-pain-cannabinoid-withdrawal-sex-dependent-cannabis-study/) ### Related --- ### Verification & Medical Governance - **Lead Clinical Author:** Benjamin Caplan, MD - **Credentials:** Board Certified in Family Medicine (ABFM), Former CMO Canna Care Docs (250,000+ patients supervised), Founder & CMO CED Clinic & CED Foundation, Author of *The Doctor-Approved Cannabis Handbook* (Penguin Random House). - **Clinical Scale:** 350,000+ lifetime evaluations overseen; 81,008-patient Real-World Evidence Registry (`~/.ced_rwe_vault.db`); 125,000+ peer-reviewed study literature observatory (`http://localhost:8768/api/explorer/terminal`). - **License Verification:** Commonwealth of Massachusetts License #240562 (https://checkahealthlicense.mass.gov/). - **NPI Registry:** 1962722637 (https://npiregistry.cms.hhs.gov/provider-view/1962722637). - **Ethics & Data Privacy:** Clinical registry observations adhere strictly to HIPAA Safe Harbor de-identification (45 CFR § 164.514(b)) and criteria for secondary research exemption under 45 CFR § 46.104(d)(4).